Author

Philippe Dessen

Centre National de la Recherche ScientifiqueORCID 0000-0002-4799-5071Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Antonin MarchaisiD· 1 shared Birgit GeoergeriD· 1 shared Catherine BrenneriD· 1 shared Christine PéchouxiD· 1 shared Clara NahmiasiD· 1 shared Cynthia Seiler· 1 shared Damarys LoewiD· 1 shared Diego ChianeseiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Antonin MarchaisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 8, 2026

Connecting mitochondrial metabolism and mitotic fidelity to control vulnerability of high grade serous ovarian cancer patients to taxane-based chemotherapy

Hadia Moindjie, Morgane Morin, Evanthia Pangou…·Clara Nahmias

This paper identifies syntabulin as a determinant of chemosensitivity in high-grade serous ovarian cancer by linking mitochondrial metabolism and mitotic fidelity.

DOI 10.64898/2026.01.07.698258

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyEMBO Molecular MedicinePeer-reviewedJul 15, 2024

DiPRO1 dependent transcriptional and epigenetic regulation distinctly controls the fate of muscle and mesenchymal cancer cells.

Jeremy Rich, Melanie Bennaroch, Laura Notel…·Iryna Pirozhkova

This paper identifies DiPRO1 as a regulator of myoblast differentiation and mesenchymal tumor suppression through epigenetic and transcriptional mechanisms, showing its potential as a therapeutic target.

2 citations

humanDNA methylation

𝕏 PostBluesky